Impact of contrast-induced acute kidney injury on the association between renin-angiotensin system inhibitors and long-term mortality in heart failure patients.
Li LeiYulu HuangZhaodong GuoFeier SongYibo HeJin LiuGuoli SunBowen LiuPengyuan ChenJianbin ZhaoDengxuan WuYan XueWenhe YanZefeng LinXiuqiong HuangGuanzhong ChenShiqun ChenYong LiuJiyan ChenPublished in: Journal of the renin-angiotensin-aldosterone system : JRAAS (2021)
RASi prescription at discharge for HF patients complicating CI-AKI tended to be ineffective, while it benefited those without CI-AKI. Further randomized evidence is needed to confirm this trend.
Keyphrases
- acute kidney injury
- ejection fraction
- cardiac surgery
- end stage renal disease
- newly diagnosed
- magnetic resonance
- double blind
- open label
- prognostic factors
- peritoneal dialysis
- cardiovascular disease
- type diabetes
- randomized controlled trial
- heart failure
- clinical trial
- cardiovascular events
- high glucose
- contrast enhanced
- placebo controlled
- magnetic resonance imaging
- oxidative stress
- patient reported outcomes
- study protocol
- acute heart failure